Beta Bionics Inc
Beta Bionics Inc (BBNX) Implied Volatility Current
BBNX implied volatility is 89%. IV Rank is —%, placing current premiums in the middle of their 52-week range.
Read more
Tracking BBNX implied volatility helps you identify when options premiums on Beta Bionics Inc are historically cheap or expensive, and where the best trades are hiding. Beta Bionics Inc implied volatility reflects the market's expectation of future price movement: when BBNX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Beta Bionics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BBNX, tracking metrics like BBNX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BBNX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.
It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BBNX implied volatility sits today versus where it has been. Our scanner ranks Beta Bionics Inc implied volatility against its historical range, surfaces extremes in BBNX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Beta Bionics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
As of September 23, 2026
Trade options with IV on your side
Track BBNX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→